Thursday, May 19, 2022
SCIENMAG: Latest Science and Health News
No Result
View All Result
  • Login
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US
No Result
View All Result
Scienmag - Latest science news from science magazine
No Result
View All Result
Home SCIENCE NEWS Cancer

Stealth nanomedicines combat cancer and cut toxic effects of chemo

March 10, 2022
in Cancer
0
Share on FacebookShare on Twitter

Nanomedicines – typically drugs hidden within nanoscopic fatty membranes (‘liposomes’) – have potential to transform chemotherapy treatments, improving drug delivery and reducing toxic side effects for thousands of cancer patients every year.

Chemotherapy

Credit: National Cancer Institute

Nanomedicines – typically drugs hidden within nanoscopic fatty membranes (‘liposomes’) – have potential to transform chemotherapy treatments, improving drug delivery and reducing toxic side effects for thousands of cancer patients every year.

 

Now, world first research conducted by the University of South Australia has identified that the frequently used chemotherapy drug (5-FU or Fluorouracil) is 100 per cent more effective at targeting tumours (rather than surrounding tissues) when administered using an optimised liposomal formulation.

 

Using a minimally invasive sampling technique known as micro-dialysis this is the first time that the biodistribution of 5-FU liposome formulations has been quantified in this way – something that could not be achieved as effectively using current imaging approaches.

 

In Australia, about 150,000 new cases of cancer are diagnosed each year. It is a leading cause of death worldwide accounting for nearly 10 million deaths a year (nearly one in six deaths).

 

Chemotherapy is regularly used to treat many cancers, with 5-FU being an important drug used in treatment. Side effects of this drug can include nausea and vomiting, fatigue, hair loss, diarrhoea or constipation, weight fluctuations, frequent infections, and mouth sores.

 

Lead researcher and co-Director at UniSA’s Centre for Pharmaceutical Innovation, Professor Clive Prestidge, says the discovery could change the way chemotherapy is administered, providing a better quality of life for thousands of cancer patients.

 

“Chemotherapy is regularly administered to treat many different types of cancers, including breast and colon cancers, but one of the major setbacks of 5-FU is that it does not distribute well to tumour issues and can cause high levels of off-target damage,” Prof Prestidge says.

 

“As a result, many patients suffer adverse effects and can get very sick during treatment.

 

“Liposomal formulations present great opportunities for safer and more effective cancer medications because they prolong the retention of encapsulated drugs and can better target tumours. But optimising them for chemotherapy drugs has always proved challenging.

 

“Our micro-dialysis approach is the first to quantify how liposomal-specific delivery of 5-FU can reduce tumour growth with fewer toxic side effects, so it has the potential to dramatically transform many cancer treatments and deliver better outcomes for people with cancer.”

 

…………………………………………………………………………………………………………………………

Contact for interview:  Prof Clive Prestidge E [email protected]
Media contact: Annabel Mansfield M: +61 417 717 504 E: [email protected]
 



Journal

Pharmaceutics

DOI

10.3390/pharmaceutics14020221

Method of Research

Experimental study

Subject of Research

Animals

Article Title

Liposomal 5-Fluorouracil Polymer Complexes Facilitate Tumor-Specific Delivery: Pharmaco-Distribution Kinetics Using Microdialysis

Article Publication Date

18-Jan-2022

Tags: cancerChemocombatcuteffectsnanomedicinesStealthToxic
Share28Tweet17Share5ShareSendShare
  • Gladstone scientists Tongcui Ma, Irene Chen, and Rahul Suryawanshi.

    “Natural immunity” from omicron is weak and limited, study finds

    68 shares
    Share 27 Tweet 17
  • Scripps Research awarded $67 million by NIH to lead new Pandemic Preparedness Center

    66 shares
    Share 26 Tweet 17
  • Researchers discover genetic cause of megaesophagus in dogs

    1022 shares
    Share 409 Tweet 256
  • Do early therapies help very young children with or at high likelihood for autism?

    66 shares
    Share 26 Tweet 17
  • Ecological functions of streams and rivers severely affected globally

    71 shares
    Share 28 Tweet 18
  • Null results research now published by major behavioral medicine journal

    310 shares
    Share 124 Tweet 78
ADVERTISEMENT

About us

We bring you the latest science news from best research centers and universities around the world. Check our website.

Latest NEWS

Understanding how sunscreens damage coral

SUTD develops design-based activity to enhance students’ understanding in electrochemistry

New Curtin research resurrects ‘lost’ coral species

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 187 other subscribers

© 2022 Scienmag- Science Magazine: Latest Science News.

No Result
View All Result
  • HOME PAGE
  • BIOLOGY
  • CHEMISTRY AND PHYSICS
  • MEDICINE
    • Cancer
    • Infectious Emerging Diseases
  • SPACE
  • TECHNOLOGY
  • CONTACT US

© 2022 Scienmag- Science Magazine: Latest Science News.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
Posting....